Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Pericarditis
Research results from P. Dipasquale and co-authors update knowledge of acute pericarditis
March 23rd, 2008
"The aim of the present study was to evaluate the safety and efficacy of the combination of indomethacin and statin compared with indomethacin plus placebo in patients with a first episode of pericarditis. A total of 55 consecutive patients with acute pericarditis were randomized in a double-blind manner into two groups: group I (statin group) was treated with 150 mg of indomethacin plus 10 mg of rosuvastatin, and group 2 (placebo group) was treated with 150 mg of indomethacin plus placebo," investigators in Palermo, Italy report. "Both groups received treatment up to the normalization of inflammation markers and for the following week. Clinical and laboratory...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-23)
|
